Key result
A single dose of standard Aspirin prolonged bleeding time and inhibited platelet aggregation for 6 days, whereas effects normalized by day 6 with enteric-coated formulations.
Why the study?
Do different formulations of a single 500 mg dose of acetylsalicylic acid have differing effects on platelet function tests in healthy young male subjects?
Do different formulations of a single 500 mg dose of acetylsalicylic acid have differing effects on platelet function tests in healthy young male subjects?
A single dose of standard acetylsalicylic acid provides more sustained inhibition of platelet aggregation and prolongation of bleeding time over 6 days compared to enteric-coated formulations.
Answers are grounded in this paper and cite their sources.
Standard aspirin may sustain platelet inhibition longer than enteric-coated; leaves open clinical relevance for bleeding or thrombotic risk in patients.
The template bleeding time (TBT), ADP-induced platelet aggregation, and serum production of TXB2 were measured in healthy young male subjects immediately before, and on days 1, 4 and 6 after the ingestion of 1 single dose of 500 mg acetylsalicylic acid (ASA) in 3 different formulations: Aspirin (Bayer), and the 2 enteric-coated formulations Reumyl (Hässle) and Premaspin (Lääke). The ingestion of Aspirin resulted in a significant prolongation of the TBT over a period of 6 d. However, after the ingestion of the same amount of ASA in the 2 enteric coated formulations, the TBT as measured on day 6 had become normalized. After the ingestion of Aspirin, there was no reappearance of the second wave of ADP-induced platelet aggregation during the study period; however, after the ingestion of the 2 enteric-coated formulations, secondary platelet aggregation occasionally returned on day 6. In response to the intake of each of the 3 ASA formulations, the serum TXB2 production as measured 24 h later was almost completely inhibited. In each of the 3 study groups, the TXB2 formation as measured on day 6 was still significantly impaired.
No takes yet. Share an insight, caveat, or question.
Kutti et al. (1984) studied Healthy. Acetylsalicylic acid (ASA) in 3 different formulations (Aspirin, Reumyl, Premaspin) vs. Baseline and between formulations was evaluated on Template bleeding time (TBT), ADP-induced platelet aggregation, and serum production of TXB2. A single dose of standard Aspirin prolonged bleeding time and inhibited platelet aggregation for 6 days, whereas effects normalized by day 6 with enteric-coated formulations.
Synapse has enriched 10 related papers. Consider them for comparative context: